Substance use and use disorders during pregnancy and the postpartum period

被引：0

作者：

Habersham, Leah L. ^{[1
,2
]}

Townsel, Courtney ^{[3
]}

Terplan, Mishka ^{[4
]}

Hurd, Yasmin L. ^{[2
]}

机构：

[1] Icahn Sch Med Mt Sinai, Dept Obstet Gynecol & Reprod Sci, New York, NY 10029 USA

[2] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA

[3] Univ Maryland, Sch Med, Dept Obstet & Gynecol, Baltimore, MD USA

[4] Friends Res Inst Inc, Baltimore, MD USA

来源：

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 2025年 / 232卷 / 04期

关键词：

alcohol; benzodiazepines; cannabis; comprehensive overview of substance use; epidemiology; ethics; intervention; maternal and fetal adverse effects; nicotine; obstetric complications; opioids; postpartum substance disorders; substance use; NEONATAL ABSTINENCE SYNDROME; SMOKING; WOMEN; BENZODIAZEPINES; GYNECOLOGISTS; MEDICINE; EXPOSURE; STATES;

D O I：

10.1016/j.ajog.2025.01.007

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Substance use and substance use disorders among pregnant and postpartum individuals have risen dramatically, necessitating enhanced clinician education and intervention strategies. This expert review offers obstetricians and gynecologists a comprehensive overview of substance use during the prenatal and postpartum periods. We discuss the epidemiology, maternal and fetal adverse effects, as well as treatment approaches for major substances: nicotine, cannabis, alcohol, benzodiazepines, stimulants, and opioids. Additionally, we address the ethical and legal implications of substance use during pregnancy and emphasize the importance of equitable and nonstigmatizing care. By integrating evidence-based practices, we aim to support obstetricians and gynecologists in providing optimal care for pregnant and postpartum individuals affected by substance use disorders.

引用

页数：18

共 50 条

[1] Optimizing Outcomes for Women With Substance Use Disorders in Pregnancy and the Postpartum Period
不详
JOGNN-JOURNAL OF OBSTETRIC GYNECOLOGIC AND NEONATAL NURSING, 2019, 48 (05): : 583 - 585
[2] Substance use and use disorder in pregnancy and postpartum
Terplan, Mishka
INTERNATIONAL REVIEW OF PSYCHIATRY, 2021, 33 (06) : 501 - 501
[3] Use of psychotropic medication during pregnancy and the postpartum period
Pearlstein, Teri
WOMENS HEALTH, 2013, 9 (06) : 605 - 615
[4] Knowledge of Maternal Mortality Risk Among Women with Substance Use Disorders during Pregnancy and Postpartum
Renbarger, Kalyn M.
Slater, Greta
Phelps, Barbara
MCN-THE AMERICAN JOURNAL OF MATERNAL-CHILD NURSING, 2024, 49 (01) : 38 - 43
[5] Mental disorders during pregnancy and postpartum period
Kammoun, I.
Kammoun, R.
Maatouk, O.
Karoui, M.
Ben Salah, K.
Ellouze, F.
EUROPEAN PSYCHIATRY, 2021, 64 : S605 - S605
[6] Coloproctologic Disorders during Pregnancy and in the Postpartum Period
Bussen, S.
Herold, A.
Schmittner, M.
Krammer, H.
Bussen, D.
GEBURTSHILFE UND FRAUENHEILKUNDE, 2008, 68 (11) : 1069 - 1073
[7] Rural Postpartum Women With Substance Use Disorders
Kramlich, Debra
Kronk, Rebecca
Marcellus, Lenora
Colbert, Alison
Jakub, Karen
QUALITATIVE HEALTH RESEARCH, 2018, 28 (09) : 1449 - 1461
[8] Management of the Cardiovascular Complications of Substance Use Disorders During Pregnancy
P. Kaitlyn Edelson
Sarah N. Bernstein
Current Treatment Options in Cardiovascular Medicine, 2019, 21
[9] Substance use disorders in women: special considerations during pregnancy
Bolnick, JM
Rayburn, WF
OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2003, 30 (03) : 545 - +
[10] Management of the Cardiovascular Complications of Substance Use Disorders During Pregnancy
Edelson, P. Kaitlyn
Bernstein, Sarah N.
CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2019, 21 (11)

← 1 2 3 4 5 →